These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6695654)
1. Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. Peter T; Hamer A; Weiss D; Mandel WJ Am Heart J; 1984 Feb; 107(2):209-13. PubMed ID: 6695654 [TBL] [Abstract][Full Text] [Related]
2. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151 [TBL] [Abstract][Full Text] [Related]
3. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Leak D Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353 [TBL] [Abstract][Full Text] [Related]
4. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Cairns JA; Connolly SJ; Roberts R; Gent M Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up. Peter T; Hamer A; Mandel WJ; Weiss D Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841 [TBL] [Abstract][Full Text] [Related]
6. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up. Peter T; Hamer A; Mandel WJ Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112 [TBL] [Abstract][Full Text] [Related]
17. Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study. Cairns JA; Connolly SJ; Gent M; Roberts R Circulation; 1991 Aug; 84(2):550-7. PubMed ID: 1860199 [TBL] [Abstract][Full Text] [Related]
18. Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Wheeler PJ; Puritz R; Ingram DV; Chamberlain DA Postgrad Med J; 1979 Jan; 55(639):1-9. PubMed ID: 432163 [TBL] [Abstract][Full Text] [Related]
19. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. Raviele A; Di Pede F; Delise P; Piccolo E G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619 [TBL] [Abstract][Full Text] [Related]
20. Long-term tolerance of amiodarone treatment for cardiac arrhythmias. Smith WM; Lubbe WF; Whitlock RM; Mercer J; Rutherford JD; Roche AH Am J Cardiol; 1986 Jun; 57(15):1288-93. PubMed ID: 3717027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]